Hormonal and Barrier Methods of Contraception, Oncogenic Human Papillomaviruses, and Cervical Squamous Intraepithelial Lesion Development
作者： Ann L. Coker , Laura C. Sanders , Sharon M. Bond , Tsilya Gerasimova , Lucia Pirisi
DOI: 10.1089/152460901300233911
关键词:
摘要: We assessed the influence of hormonal (oral, injectable, or levonorgestrel [Norplant, Wyeth-Ayerst, Philadelphia, PA]) and barrier methods contraception on risk cervical squamous intraepithelial lesions (SIL), while adjusting for high-risk (HR) HPV infection. Subjects were women receiving family planning services through state health department clinics from 1995 to 1998. selected 60 cases with high-grade cervical/SIL (HSIL) 316 low-grade (LSIL) controls (427 normal cytology) analyzed DNA HR-HPV, using Hybrid Capture I (Digene; Gaithersburg, MD). When assessing ever use, duration, recency, latency, age at first neither oral contraceptives (OC), Norplant, nor injectable use was associated an increased SIL development after age, sexual intercourse, HR-HPV positivity. Among HR-HPV-positive women, longer duration method a reduced SIL. This ...
liebertonline.com参考文章(52)
Rezza, Giuliani, Branca, Benedetto, Migliore, Garbuglia, D'Ubaldo, Pezzotti, Cappiello, Pomponi Formiconi, Suligoi, Schiesari, Ippolito, Giacomini, The DIANAIDS Collaborative Study Group, Determinants of squamous intraepithelial lesions (SIL) on Pap smear: The role of HPV infection and of HIV-1-induced immunosuppression European Journal of Epidemiology. ,vol. 13, pp. 937- 943 ,(1997) , 10.1023/A:1007466908865
Muñoz N, Bosch Fx, HPV and cervical neoplasia: review of case-control and cohort studies. IARC scientific publications. pp. 251- ,(1992)
DAVID D. CELENTANO, ANN C. KLASSEN, CAROL S. WEISMAN, NEIL B. ROSENSHEIN, THE ROLE OF CONTRACEPTIVE USE IN CERVICAL CANCER: THE MARYLAND CERVICAL CANCER CASE-CONTROL STUDY American Journal of Epidemiology. ,vol. 126, pp. 592- 604 ,(1987) , 10.1093/OXFORDJOURNALS.AJE.A114699
Fabio Parazzini, Eva Negri, Carlo La Vecchia, Luigi Fedele, Barrier methods of contraception and the risk of cervical neoplasia Contraception. ,vol. 40, pp. 519- 530 ,(1989) , 10.1016/0010-7824(89)90125-X
David C.G. Skegg, Oral contraceptives and neoplasia: An introduction Contraception. ,vol. 43, pp. 521- 525 ,(1991) , 10.1016/0010-7824(91)90001-V
William C. Reeves, Louise A. Brinton, Mariana García, María M. Brenes, Rolando Herrero, Eduardo Gaitán, Francisco Tenorio, Rosa C. de Britton, William E. Rawls, Human papillomavirus infection and cervical cancer in Latin America. The New England Journal of Medicine. ,vol. 320, pp. 1437- 1441 ,(1989) , 10.1056/NEJM198906013202201
David B. Thomas, Roberta M. Ray, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix Contraception. ,vol. 52, pp. 307- 312 ,(1995) , 10.1016/0010-7824(95)00215-V
Kathleen L. Irwin, Oral Contraceptives and Cervical Cancer Risk in Costa Rica JAMA. ,vol. 259, pp. 59- 64 ,(1988) , 10.1001/JAMA.1988.03720010037037
F. X. Bosch, N. Muñoz, S. de Sanjosé, I. Izarzugaza, M. Gili, P. Viladiu, M. J. Tormo, P. Moreo, N. Ascunce, L. C. Gonzalez, L. Tafur, J. M. Kaldor, E. Guerrero, N. Aristizabal, M. Santamaria, P. Alonso De Ruiz, K. Shah, Risk factors for cervical cancer in Colombia and Spain International Journal of Cancer. ,vol. 52, pp. 750- 758 ,(1992) , 10.1002/IJC.2910520514
F Parazzini, L Chatenoud, C La Vecchia, F Chiaffarino, E Ricci, E Negri, Time since last use of oral contraceptives and risk of invasive cervical cancer European Journal of Cancer. ,vol. 34, pp. 884- 888 ,(1998) , 10.1016/S0959-8049(97)10139-3